
SI Stock Forecast & Price Target
SI Analyst Ratings
Bulls say
Shoulder Innovations is viewed positively because its Q2 results were largely in line with estimates while gross margin was notably stronger, and management raised 2026 revenue guidance to $67M-$69M after reporting $17.2M in revenue, up 56.0% year over year. The investment case is reinforced by accelerating surgeon additions, higher unit growth and ASPs, and a broad pipeline of new products that could expand the addressable market and support further top-line growth, including a robotic offering targeted for FDA submission in the first half of 2027. Its differentiated, capital-light shoulder franchise also benefits from durable clinical advantages, strong gross margins, and an expanding customer base, making the stock appealing on weakness.
Bears say
Shoulder Innovations is facing a fundamentally fragile growth profile because its 2Q26 revenue of about $17.2M and 56.0% Y/Y growth were supported by only ~2,238 implant systems sold, leaving performance highly dependent on surgeon adoption rather than a broad, durable demand base. The company’s guidance for FY26 implies $67M-$69M in revenue, but it also signals weaker 3Q26 seasonality, higher operating expenses as a percentage of sales in 3Q26, and likely ASP pressure in 4Q from procedure mix, all of which threaten margin expansion. Bearish conviction is reinforced by explicit downside risks including slower uptake by a smaller-than-modeled group of new surgeons, lower shoulder market growth, faster ASP degradation, later entry into new market segments, and higher operating spend than expected.
This aggregate rating is based on analysts' research of Shoulder Innovations LLC and is not a guaranteed prediction by Public.com or investment advice.
SI Analyst Forecast & Price Prediction
Start investing in SI
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Shoulder Innovations LLC (SI) Forecast
SI Analyst Forecast & Price Prediction
Start investing in SI
Order type
Buy in
Order amount
Est. shares
0 shares